🔗 Visit the ClinicalTrials.gov page for NCT00804856
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy. | Leukemia | 2014 | 1.28 |
| 2 | Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy. | Blood | 2014 | 1.21 |